...Good morning. I'm Alan Holmer, Chairman of the Board of Directors of Corbus Pharmaceuticals Holdings Inc. I'd like to welcome each of you to our Annual Meeting of Stockholders being held this year by remote communication. Before I begin the formal portion of the meeting, I would like to take this opportunity to introduce our representatives in attendance today Gene Capello, who will act as the independent inspector of elections, Dr. Yuval Cohen, our Chief Executive Officer; Sean Moran, our Chief Financial Officer; and Meghan Houghton, our Vice President of Finance; Stephen Zapp and Donna Kalia from Lowenstein Sandler are outside corporate and securities council, and Mark Fogarty from EisnerAmper, our independent registered public accounting firm, are also present. After the formal portion of the meeting has been completed, we will provide time for general questions. Only validated stockholders will be able to ask questions in the designated field on the web portal. Out of consideration...